Filing Analysis
Blue Ridge Bankshares, Inc. is amending its previous 8-K to report the elimination of the Chief Operations and Technology Officer position. M. Dean Brown will be terminated without cause effective June 30, 2026, as part of company-wide cost reduction efforts.
🚩 Red Flags
- Elimination of a C-suite role (Chief Operations and Technology Officer) often signals aggressive cost-cutting or restructuring.
- Departure of key technology leadership can pose operational risks during transition periods.
📋 Key Facts
- Effective date of termination: June 30, 2026
- Position being eliminated: Chief Operations and Technology Officer (COTO)
- Reason for departure: Position elimination as part of cost reduction efforts
- Nature of departure: Terminated without cause
- Individual departing: M. Dean Brown
Blue Ridge Bankshares, Inc. completed a previously disclosed exchange of securities with Castle Creek Capital Partners VIII, LP on November 7, 2024. The transaction involved exchanging Series C Preferred Stock for Common Stock and warrants.
🚩 Red Flags
- Significant dilution: The issuance of over 10 million common shares and a warrant for an additional 5.7 million shares represents substantial potential dilution for existing shareholders.
- Convertible/Exchange structure: The exchange of preferred stock for common stock often indicates a restructuring of debt or preferred equity that can pressure the share price upon conversion.
📋 Key Facts
- Date of event: November 7, 2024
- The Company issued 10,928,000 shares of Common Stock to Castle Creek Capital Partners VIII, LP.
- In exchange, the Company received 2,732 shares of Series C Preferred Stock from Castle Creek.
- The Company issued a warrant to Castle Creek exercisable into 5,764,000 shares of Common Stock.
- The exercise price for the Common Stock Warrant is $2.50 per share.
- The warrant is exercisable at any time until April 3, 2029.
Blue Ridge Bankshares, Inc. updated its investor presentation on November 6, 2024, to support ongoing meetings with investors.
📋 Key Facts
- The company released an updated investor presentation (Exhibit 99.1).
- The disclosure was made under Item 7.01 (Regulation FD Disclosure) and is being furnished, not filed.
- The update is intended for use in meetings with investors.
Blue Ridge Bankshares, Inc. filed an 8-K to furnish its third quarter 2024 financial results press release. This is a routine earnings announcement filing.
📋 Key Facts
- Report date: October 29, 2024
- Reporting period: Third quarter ended September 30, 2024
- The company issued an earnings press release as Exhibit 99.1
- Filed under Item 2.02 (Results of Operations and Financial Condition)
Blue Ridge Bankshares, Inc. held its 2024 Annual Meeting of Shareholders on October 10, 2024. The company successfully passed all proposals, including the election of directors, approval of a stock incentive plan, and ratification of their independent auditor.
📋 Key Facts
- Annual Meeting held on October 10, 2024.
- Quorum was established with 58,555,687 shares present (out of 73,541,950 outstanding).
- Seven directors were elected to terms expiring in 2025, 2026, and 2027.
- The Amended and Restated 2023 Stock Incentive Plan was approved by shareholders.
- Elliott Davis, PLLC was ratified as the independent registered public accounting firm for 2024.
Blue Ridge Bankshares, Inc. announced the separation of employment for C. Douglass Riddle, who served as Executive Vice President and Commercial Banking Executive at its wholly-owned subsidiary, Blue Ridge Bank, National Association.
🚩 Red Flags
- Departure of a high-level executive (Executive Vice President) in the commercial banking division.
📋 Key Facts
- C. Douglass Riddle's departure is effective September 9, 2024.
- Mr. Riddle held the roles of Executive Vice President and Commercial Banking Executive.
- Compensation and benefits will be governed by his employment agreement dated October 23, 2023.
Blue Ridge Bankshares, Inc. announced the date for its 2024 annual meeting of shareholders and provided deadlines for director nominations and shareholder proposals.
📋 Key Facts
- The 2024 annual meeting of shareholders is scheduled for October 10, 2024.
- Written notice for director nominations must be received by the Corporate Secretary no later than August 10, 2024.
- Shareholder proposals must meet Rule 14a-8 requirements and be received by August 10, 2024.
Blue Ridge Bankshares, Inc. filed an 8-K to furnish its second quarter 2024 financial results press release. This is a routine earnings announcement filing.
📋 Key Facts
- Report date: July 25, 2024
- Reporting period: Second Quarter ended June 30, 2024
- The filing includes Exhibit 99.1 containing the press release of financial results.
Blue Ridge Bankshares, Inc. filed an amendment to its previous 8-K to announce that Tony Scavuzzo has received regulatory approval and was appointed to the Compensation Committee effective June 26, 2024.
📋 Key Facts
- Tony Scavuzzo appointed to the Compensation Committee of the Board effective June 26, 2024.
- Appointment is subject to receiving required approvals by applicable regulatory agencies (now obtained).
- The filing serves as an amendment (8-K/A) to a previous report filed on April 5, 2024.
- Ciaran McMullan and Trevor Montano were previously appointed but committee assignments for all new directors were pending in the original filing.
Blue Ridge Bankshares, Inc. has completed the automatic conversion of its Series B Preferred Stock into common stock following shareholder approval and regulatory filings. This event results in a massive increase in the total number of outstanding common shares due to dilution.
🚩 Red Flags
- Significant equity dilution: The conversion of Series B alone added over 50 million shares to the float.
- Potential for further massive dilution in Q3 2024 via the conversion of Series C Preferred Stock.
- The conversion was triggered by a requirement to avoid exceeding 20% ownership limits, suggesting complex capital restructuring.
📋 Key Facts
- On June 28, 2024, all 12,558 shares of Series B Preferred Stock converted into 50,232,000 shares of Common Stock.
- Warrants exercisable into 6,549 shares of Series B Preferred Stock converted into warrants for 26,196,000 shares of Common Stock.
- Shareholder approval was obtained on June 20, 2024, to increase authorized common stock to at least 150,000,000 shares.
- Series C Preferred Stock is expected to convert into common stock during Q3 2024.
This 8-K/A is an amendment to a previous filing regarding the appointment of new directors. It confirms that Ciaran McMullan and Trevor Montano have received regulatory approval and specifies their committee assignments within the Bank's Board of Directors.
📋 Key Facts
- Ciaran McMullan appointed to the Compliance Committee of the Bank’s Board of Directors, effective June 18, 2024.
- Trevor Montano appointed to the Enterprise Risk Committee of the Bank’s Board of Directors, effective June 18, 2024.
- Both individuals received required regulatory approval for their appointments.
- The filing serves as an amendment (8-K/A) to the original report filed on April 5, 2024.
Blue Ridge Bankshares, Inc. announced the approval of several shareholder proposals, including a significant increase in authorized common stock shares and the approval to issue shares representing more than 20% of outstanding stock upon conversion of preferred stock/warrants.
🚩 Red Flags
- Potential significant dilution for existing shareholders due to the conversion of Series B and Series C preferred stock/warrants (exceeding 20% threshold).
- Massive increase in authorized share count (from 50M to 150M) provides management with significant headroom for future dilutive equity issuances.
📋 Key Facts
- Shareholders approved Proposal 1: Issuance of common stock representing >20% of outstanding shares via conversion of Series B and Series C preferred stock and warrants.
- Shareholders approved Proposal 2: Amendment to Articles of Incorporation to increase authorized common stock from 50,000,000 to 150,000,000 shares.
- Five directors (Richard A. Farmar, III, Andrew C. Holzwarth, Robert S. Janney, Mensel D. Dean, Jr., and Larry Dees) are retiring effective at the 2024 Annual Meeting on September 25, 2024.
- The Special Meeting held on June 20, 2024, established a quorum with 18,680,396 shares present in person or by proxy.
Blue Ridge Bankshares, Inc. completed a private placement of equity securities on June 13, 2024, raising approximately $11.6 million from an existing shareholder. The offering included common stock, preferred stock, and warrants.
🚩 Red Flags
- Related-party transaction: The primary purchaser is an existing shareholder (Richard T. Spurzem), which can indicate a need for external capital that public markets are unwilling to provide.
- Potential dilution: The issuance of 290,000 common shares and the inclusion of warrants will result in significant dilution for existing minority shareholders.
📋 Key Facts
- Total gross proceeds from the private placement: approximately $11.6 million.
- Closing date of the transaction: June 13, 2024.
- Securities issued: 290,000 Common Shares at $2.39 per share; 1,140 shares of Series B Preferred Stock at $9,566.13 per share; and a warrant to purchase 607 shares of Series B Preferred Stock.
- The transaction was conducted with Richard T. Spurzem, an existing shareholder of the Company.
- The offering was exempt from registration under Section 4(a)(2) of the Securities Act and Rule 506(b) of Regulation D.
Blue Ridge Bankshares, Inc. entered into a $11.6 million Securities Purchase Agreement with shareholder Richard T. Spurzem to issue common and preferred stock. This follows a much larger $150 million issuance in April 2024, indicating significant ongoing capital needs.
🚩 Red Flags
- Significant dilution risk due to massive increase in authorized shares (up to 150 million).
- Related-party transaction: The purchaser is a significant shareholder (Mr. Spurzem) exercising gross-up rights.
- Heavy use of convertible preferred stock which can lead to rapid downward pressure on share price upon conversion.
- Liquidated damages clause in the Registration Rights Agreement indicates high pressure on management to maintain compliance.
📋 Key Facts
- Entered into a Private Placement agreement on June 7, 2024, for approximately $11.6 million.
- The offering involves Common Shares, Series B Preferred Shares, and Warrants issued to Richard T. Spurzem.
- Conversion of preferred shares is contingent upon stockholder approval to increase authorized common stock to at least 150,000,000 shares.
- Initial conversion rate for preferred shares is 4,000 common shares per $50 preferred share (implying a $0.0125 conversion price, though the text notes an initial conversion rate based on $2.50/share).
- The company will pay 1.0% monthly liquidated damages if it fails to register the securities within specified deadlines.
- Proceeds are intended for general corporate purposes, repositioning business lines, and enhancing capital levels of Blue Ridge Bank, N.A.
Blue Ridge Bankshares, Inc. filed an 8-K to announce its financial results for the first quarter ended March 31, 2024. The filing serves as a formal mechanism to furnish the quarterly press release to the SEC.
📋 Key Facts
- Report date: April 30, 2024
- Reporting period: First Quarter ended March 31, 2024
- The filing includes Exhibit 99.1 (Press Release) regarding financial results.
- Company is classified as an emerging growth company.
Blue Ridge Bankshares, Inc. entered into an Amended and Restated Securities Purchase Agreement on April 3, 2024, involving a $150 million private placement of common stock, preferred stock, and warrants to Kenneth R. Lehman, Castle Creek Capital Partners VIII, LP, and other investors. The deal includes significant governance changes, including board designation rights for the lead investor.
🚩 Red Flags
- Significant dilution risk due to massive increase in authorized shares (up to 150M) and convertible preferred stock.
- Loss of control: Lead investor Castle Creek gains board designation rights.
- Existence of 'work-out assets' suggests the bank is managing distressed or non-performing loans requiring an accelerated resolution strategy.
- Complexity of conversion rates (4,000 shares per Preferred Share) and anti-dilution protections for investors.
📋 Key Facts
- Total gross proceeds from the private placement: $150,000,000.
- Securities issued include 3.4 million Common Shares at $2.50/share, Series B Preferred Stock, and Series C Preferred Stock.
- Warrants were issued to non-insider purchasers for up to 7,383 shares of preferred stock.
- Castle Creek is entitled to designate two individuals to the Company's and the Bank's boards of directors (subject to regulatory approval).
- The company will seek shareholder approval by June 17, 2024, to increase authorized common stock to at least 150,000,000 shares.
- The agreement includes a mandate for the company and Mr. Lehman to develop an 'asset resolution plan' regarding 'work-out assets'.
Blue Ridge Bankshares, Inc. announced the closing of a private placement of securities involving Kenneth R. Lehman and Castle Creek Capital Partners VIII, LP. The announcement follows significant uncertainty regarding shareholder vote tabulation errors during a March 2024 special meeting.
🚩 Red Flags
- Significant governance/administrative risk: Potential errors in shareholder vote tabulation by a third-party transfer agent.
- Regulatory/Compliance risk: Possible violation of NYSE rules regarding non-routine matter voting procedures.
- Complexity in capital structure: The private placement is tied to an increase in authorized shares that was subject to disputed voting results.
📋 Key Facts
- Closed a private placement of securities with investors including Kenneth R. Lehman and Castle Creek Capital Partners VIII, LP on April 3, 2024.
- A shareholder inquiry revealed potential errors in vote tabulation by a third-party firm regarding Proposal 2 (increasing authorized shares from 50M to 150M).
- The company noted that the tabulation error might have violated NYSE rules regarding non-routine matters.
- Despite the voting uncertainty, the Board of Directors moved forward to approve the amendments and the Private Placement.
Blue Ridge Bankshares, Inc. held a Special Meeting of Shareholders on March 6, 2024, where shareholders approved two major proposals: a capital raise involving the issuance of >20% of outstanding common stock and an amendment to increase authorized shares from 50 million to 150 million.
🚩 Red Flags
- Significant dilution risk: The approved capital raise involves issuing more than 20% of the company's outstanding common stock.
- Massive increase in authorized share pool: Increasing authorized shares from 50M to 150M provides significant headroom for further dilutive issuances.
📋 Key Facts
- Shareholders approved Proposal 1: Issuance of common stock representing more than 20% of outstanding shares in a private placement (Capital Raise Proposal).
- Shareholders approved Proposal 2: Amendment to Articles of Incorporation to increase authorized shares from 50,000,000 to 150,000,000.
- A quorum was established with 17,419,871 shares present (out of 19,198,379 outstanding).
- The Capital Raise Proposal received 12,655,931 votes 'For'.
- The Articles Amendment Proposal received 15,291,932 votes 'For'.
Blue Ridge Bankshares, Inc. filed an 8-K to announce its financial results for the fourth quarter ended December 31, 2023.
📋 Key Facts
- Report date: January 31, 2024
- Reporting period: Fourth quarter ended December 31, 2023
- The filing includes a press release (Exhibit 99.1) regarding financial results.
- Company is an emerging growth company.
Blue Ridge Bank, National Association (a subsidiary of Blue Ridge Bankshares, Inc.) has entered into a Consent Order with the OCC, replacing a previous 2022 Written Agreement. The bank is now deemed to be in 'troubled condition' due to deficiencies in BSA/AML compliance and third-party risk management.
🚩 Red Flags
- Deemed in 'troubled condition' by federal regulators (OCC).
- Loss of 'eligible bank' status, limiting expedited regulatory reviews.
- Significant restrictions on operational growth, specifically regarding third-party fintech partnerships and executive hiring/promotion.
- Strict capital ratio requirements (10% leverage / 13% total capital) to avoid being deemed 'undercapitalized'.
- Mandatory OCC non-objection required for dividends or capital distributions.
📋 Key Facts
- The Bank was deemed to be in 'troubled condition' by the OCC as of January 24, 2024.
- The Order replaces a formal written agreement from August 29, 2022.
- Mandatory requirement to maintain a leverage ratio of 10.00% and a total capital ratio of 13.00%.
- Bank must obtain OCC non-objection prior to onboarding new third-party fintech relationships or offering new products via existing ones.
- The Bank is restricted from adding/replacing board members or promoting senior executives without notifying the OCC.
- Requires a three-year strategic plan and capital plan subject to OCC review and non-objection.